Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.
Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J.
J Clin Invest. 1993 Aug;92(2):883-93. doi: 10.1172/JCI116663.
Lipids and Cardiovascular Risk with CKD.
Afshinnia F, Pennathur S.
Clin J Am Soc Nephrol. 2020 Jan 7;15(1):5-7. doi: 10.2215/CJN.13531119. Epub 2019 Dec 12.
Lipoprotein carriers of microRNAs.
Michell DL, Vickers KC.
Biochim Biophys Acta. 2016 Dec;1861(12 Pt B):2069-2074. doi: 10.1016/j.bbalip.2016.01.011. Epub 2016 Jan 26.
Biochemistry, Low Density Lipoprotein.
Venugopal SK, Anoruo M, Jialal I.
2023 Apr 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Biochemistry, Intermediate Density Lipoprotein.
Narang D, Al-Horani RA.
2025 Feb 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Lipoprotein heterogeneity and apolipoprotein B metabolism.
Packard CJ, Shepherd J.
Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3542-56. doi: 10.1161/01.atv.17.12.3542.
Associations of intra-pancreatic fat deposition with triglyceride-rich lipoproteins and lipoprotein lipase.
Liu Y, Skudder-Hill L, Kimita W, Shamaitijiang X, Sequeira-Bisson IR, Petrov MS.
Diabetes Obes Metab. 2025 Jun;27(6):3233-3241. doi: 10.1111/dom.16338. Epub 2025 Mar 14.
Triglyceride-Rich Lipoproteins: Their Role in Atherosclerosis.
Castillo-Núñez Y, Morales-Villegas E, Aguilar-Salinas CA.
Rev Invest Clin. 2022 Mar 15;74(2):061-070. doi: 10.24875/RIC.21000416.
IDL, VLDL, chylomicrons and atherosclerosis.
Nordestgaard BG, Tybjaerg-Hansen A.
Eur J Epidemiol. 1992 May;8 Suppl 1:92-8. doi: 10.1007/BF00145358.
Biochemistry, Very Low Density Lipoprotein.
Juarez Casso FM, Farzam K.
2022 Dec 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
